Distil PLC Issues Trading Update with Revenue Warning and Funding Need

Distil warns of revenue shortfall due to trade destocking, despite strong consumer demand. Immediate funding need and US launch delay add pressure. Analysis inside.

Hide Me

Written By

Joshua
Reading time
» 6 minute read 🤓
Share this

Unlock exclusive content ✨

Just enter your email address below to get access to subscriber only content.
Join 131 others ⬇️
Written By
Joshua
READING TIME
» 6 minute read 🤓

Un-hide left column

Distil’s revenue warning: what changed in Q4 and why it matters

Distil PLC has warned that Q4 revenues will be significantly below forecast and full-year revenue will be materially below market expectations. As a result, the loss before tax for the year to 31 March 2026 will be greater than anticipated. There are no hard numbers in this update, so we don’t know the scale – but the direction is clearly negative.

Under the bonnet, the core issue is stock sitting in the trade – wholesalers and retailers holding more inventory than expected. That has muted orders flowing back to Distil, even as shoppers have been buying. In other words, end-customer demand did improve in Q3 and Q4, but distributors drew down existing stock rather than placing fresh orders.

End-demand is healthier than shipments: the de-stocking gap

Distil says sales to end customers rose in both Q3 and Q4, serviced by inventory already in the system. In the UK specifically, “sales out” from Distil’s distributor to its customers were up 51% year-on-year across January and February. Sales out refers to what the distributor sells to retailers, as opposed to Distil’s own sales in to the distributor.

RedLeg Spiced Rum continues to do the heavy lifting. Over Christmas, RedLeg consumer sales were up 36% year-on-year, versus a spirits category that fell 5.2% in value in the 12 weeks to 3 January 2026 (WSTA via NIQ Scantrack / CGA). That’s a standout performance in a shrinking market.

Macro and duty headwinds: pricing pressure is real

Management points to a weak consumer backdrop and repeated spirits duty hikes since August 2023. The latest increase on 1 February 2026 pushed retail prices up by another 50p per bottle (minimum) on Distil’s core products. In the 12 weeks to 3 January 2026, the UK spirits market value declined 0.9%, driven by a 2.4% drop in the off-trade, which means retail sales through supermarkets and shops rather than bars and restaurants.

With household budgets still tight, higher shelf prices plus a shift towards value options make premium brands work harder to keep momentum. Distil is responding with more promotions in Q1 across major grocery accounts, but that typically trims margins in the near term.

US launch setback: Blavod delays tied to CBMA paperwork

The US distribution launch of Blavod Black Vodka has been delayed due to a hold-up in the Craft Beverage Modernization Act (CBMA) submission. CBMA allows foreign producers to assign reduced excise tax rates and credits to US importers – a material factor in pricing and margins. The distributor expects the issue to be resolved in Q1 of the next financial year.

That means a near-term revenue opportunity is pushed to the right, though not cancelled. Getting this over the line will be a useful catalyst when it lands.

Brand-building and costs: promotions now, brand home opens

To soften the short-term sales decline, Distil has agreed increased promotional activity through Q1 in key grocery accounts and is continuing to remove or reduce discretionary costs. Near-term, that’s the right lever to unclog trade inventory and support share – but expect some margin trade-off until ordering patterns normalise.

On the brand side, the Blackwoods Brand Home opened in the quarter, is generating revenue, and has earned 5-star Google reviews. Trade interest – including tour operators – ahead of peak tourist season is encouraging. Management plans to focus on awareness and footfall next year to build this into a meaningful brand asset.

Funding alert: immediate short-term need under review

The combination of a weak Q4 and full-year shortfall has created an immediate short-term funding need. The Board is exploring options, but the form, size and timing are not disclosed. Until that’s clarified, investors should assume higher-than-normal risk of dilution or additional debt costs depending on the route chosen.

Distil is also reviewing arrangements with distributors and route to market, with negotiations ongoing. Any improvements here – better phasing, tighter inventory management, or incentives aligned to sell-through – would help smooth the sales in vs sales out mismatch.

Ardgowan update: production delays and funding knock-on

At Ardgowan Distillery, production of new-make spirit continues but is behind schedule due to power supply issues. Because debt drawdown is linked to production volumes, Ardgowan has a temporary funding gap and is exploring bridging options. Management expects the situation to normalise when production returns to schedule towards the end of this calendar year.

Distil holds £3.0 million of Convertible Loan Notes in Ardgowan with a 6.5% coupon. On conversion, at a £30 million pre-money valuation, these convert into 10.5% of Ardgowan’s equity at the time of conversion. The delay adds timeline risk around coupon receipts and conversion optionality, but the asset continues to mature casks for future bottling.

Key numbers and datapoints at a glance

Q4 revenue vs forecast Significantly below (no figures disclosed)
Full-year revenue vs expectations Materially below market expectations
Full-year loss before tax Greater than anticipated (not disclosed)
UK distributor sales out (Jan-Feb) +51% year-on-year
RedLeg consumer sales (Christmas period) +36% year-on-year
Spirits category value (12 weeks to 3 Jan 2026) -0.9% overall; off-trade -2.4%
Duty increase (effective 1 Feb 2026) At least +£0.50 per bottle on core products
US Blavod launch Delayed; CBMA submission expected to be resolved in Q1 FY27
Funding need Immediate; options under review (not disclosed)
Ardgowan production Behind schedule; expected back on track towards year-end
Ardgowan instrument £3.0m Convertible Loan Notes, 6.5% coupon; potential 10.5% equity on conversion at £30m pre-money

Jargon buster: quick definitions

  • Sales in vs sales out: sales in are shipments from Distil to distributors; sales out are what distributors sell to their retail customers.
  • Off-trade: retail channels like supermarkets and shops, as opposed to on-trade (bars, pubs, restaurants).
  • CBMA: a US scheme that lets foreign producers allocate reduced excise tax rates and credits to importers, affecting pricing and margins.
  • Convertible Loan Notes: debt that pays interest and can convert into equity on set terms, here tied to a £30 million pre-money valuation.
  • Inside information: material, price-sensitive information disclosed in line with UK Market Abuse Regulations.

What I’ll be watching next

  • Funding decision and terms – equity, debt or hybrid – and any implications for dilution or cost of capital.
  • Distributor negotiations – evidence of improved ordering patterns as trade inventory normalises.
  • US Blavod timing – confirmation that CBMA admin clears and first shipments land in Q1 of the new financial year.
  • Promotional effectiveness – does Q1 promo support sales without unduly eroding margins.
  • Brand Home traction – bookings and revenue as tourist season ramps up.
  • Ardgowan progress – production back on schedule and clarity on bridging finance.

My take: tough quarter, but demand signals aren’t broken

This is a clear miss on revenue and profit, and the immediate funding need is the headline risk. However, the data points on consumer sell-through are better than the shipment picture suggests, with RedLeg notably outpacing a falling category. That supports the view that de-stocking – not brand irrelevance – is the core problem.

Execution now matters: clear the channel, land the US Blavod launch, keep promotions tight, and secure funding on sensible terms. Until funding is clarified, caution is warranted. But if the company can normalise trade inventories and ride out duty pressure, there’s a path to stabilisation with some near-term catalysts in sight.

Disclaimer: This Blog is provided for general information about investments. It does not constitute investment advice. Information is taken from publicly available sources and any comment is that of the author who does not take any third party comment in the publication.
Last Updated

March 24, 2026

Category
Views
10
Likes
0

You might also enjoy 🔍

Minimalist digital graphic with a yellow-orange background, featuring 'Investing' in bold white letters at the centre and the 'Joshua Thompson' logo below.
Author picture
Surgical Innovations reports FY25 results: revenue holds at £11.6m, margins rise, but profitability slips. Strategic review and board refresh aim to optimise growth.
This article covers information on Surgical Innovations Group PLC.
Minimalist digital graphic with a yellow-orange background, featuring 'Investing' in bold white letters at the centre and the 'Joshua Thompson' logo below.
Author picture
GRID’s 2025 results show robust NAV growth and rising cash flows, despite grid connection delays pushing some key projects to 2029.
This article covers information on Gresham House Energy Storage Fund.

Comments 💭

Leave a Comment 💬

No links or spam, all comments are checked.

First Name *
Surname
Comment *
No links or spam - will be automatically not approved.

Got an article to share?